PRESS RELEASE - CEC CAPITAL

Yantai Dongcheng Biochemicals (002675) Announces Acquisition of Rongcheng Medicine's Liver Function Assessment Nuclear Medicine Product, with CEC Capital Serving as Exclusive Financial Advisor to the Seller

2024-02-21
Affection Animal Pharmaceuticals Raises Hundreds of Millions in Series C Funding, with CEC Capital Serving as Exclusive Financial Advisor

2024-02-20
Blue Sail Medical (002382.SZ) Announces RMB 900 Million Capital Increase for its Wholly-Owned Subsidiary, Blue Sail Biosensors, with CEC Capital Serving as Exclusive Financial Advisor

2024-01-26
Rokid Raises Nearly RMB 500 Million in Large-Scale Financing, With Deep Involvement From Hefei Municipal Government and CEC Capital Serving as Exclusive Financial Advisor

2024-01-09
QL Biopharm has successfully concluded a B+ round of financing, securing nearly 200 million, with CEC Capital serving as the exclusive financial advisor.

2023-11-27
Yuan Planet has recently completed consecutive rounds of funding, totaling tens of millions of dollars, with CEC Capital serving as the exclusive financial advisor.

2023-09-21
Honest accomplished a new funding round with CEC Capital acting as the exclusive financial advisor.

2023-09-05
Sinovation Completes D+ Round Financing with CEC Capital Continuing as Exclusive Financial Advisor

2023-07-31
Eccogene Secures RMB 180 Million in Series B Financing with CEC Capital as Financial Advisor

2023-06-12
BOSIN Secures Significant New Funding with CEC Capital as Financial Advisor

2023-05-09

<
1
2
3
4
5
6

...

>

Media Contacts

CHINA

Bonnie Guo

Tel：+86 (10) 8519 2080

Fax：+86 (10) 8519 2078

bonnie.guo@ceccapitalgroup.com

Social Media